Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


Phacilitate Leaders Europe Agenda


Panel Discussion: There is no one-size-fits-all when it comes to automation - how do therapy manufacturers and developers find the right size for them and when is the right time to consider this?

18 Sep 2019
Manufacturing & Commercialisation
David Kneen, VP, Cell Therapy - Invetech
Silvio Weber, Head of the Industrial Process Development Team - Miltenyi Biotec
Zami Aberman, Executive chairman - Pluristem
Robert Thomas, Professor of Manufacturing for Cell and Gene Therapies - Loughborough University
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd